DaVita Share Holder Equity 2010-2024 | DVA

DaVita share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  • DaVita share holder equity for the quarter ending March 31, 2024 was $1.133B, a 11.04% increase year-over-year.
  • DaVita share holder equity for 2023 was $1.244B, a 42.03% increase from 2022.
  • DaVita share holder equity for 2022 was $0.876B, a 6.44% decline from 2021.
  • DaVita share holder equity for 2021 was $0.936B, a 40.25% decline from 2020.
DaVita Annual Share Holder Equity
(Millions of US $)
2023 $1,244
2022 $876
2021 $936
2020 $1,567
2019 $2,319
2018 $3,908
2017 $4,886
2016 $4,850
2015 $5,084
2014 $5,360
2013 $4,606
2012 $3,917
2011 $2,268
2010 $2,037
2009 $2,194
DaVita Quarterly Share Holder Equity
(Millions of US $)
2024-03-31 $1,133
2023-12-31 $1,244
2023-09-30 $1,379
2023-06-30 $1,206
2023-03-31 $1,020
2022-12-31 $876
2022-09-30 $702
2022-06-30 $775
2022-03-31 $1,018
2021-12-31 $936
2021-09-30 $1,328
2021-06-30 $1,463
2021-03-31 $1,433
2020-12-31 $1,567
2020-09-30 $1,753
2020-06-30 $2,334
2020-03-31 $2,133
2019-12-31 $2,319
2019-09-30 $2,513
2019-06-30 $4,243
2019-03-31 $4,087
2018-12-31 $3,908
2018-09-30 $4,029
2018-06-30 $4,485
2018-03-31 $4,782
2017-12-31 $4,886
2017-09-30 $4,969
2017-06-30 $5,272
2017-03-31 $5,341
2016-12-31 $4,850
2016-09-30 $5,119
2016-06-30 $4,959
2016-03-31 $4,922
2015-12-31 $5,084
2015-09-30 $5,192
2015-06-30 $5,347
2015-03-31 $5,171
2014-12-31 $5,360
2014-09-30 $5,151
2014-06-30 $4,957
2014-03-31 $4,838
2013-12-31 $4,606
2013-09-30 $4,437
2013-06-30 $4,282
2013-03-31 $3,957
2012-12-31 $3,917
2012-09-30 $2,670
2012-06-30 $2,508
2012-03-31 $2,402
2011-12-31 $2,268
2011-09-30 $2,082
2011-06-30 $1,946
2011-03-31 $2,137
2010-12-31 $2,037
2010-09-30 $2,376
2010-06-30 $2,357
2010-03-31 $2,319
2009-12-31 $2,194
2009-09-30 $2,138
2009-06-30 $2,056
2009-03-31 $1,924
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.399B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.911B 0.00
Quest Diagnostics (DGX) United States $15.437B 15.95
Elanco Animal Health (ELAN) United States $8.920B 23.14
Encompass Health (EHC) United States $8.544B 21.87
Chemed (CHE) United States $8.213B 25.46
Option Care Health (OPCH) United States $4.898B 18.54
RadNet (RDNT) United States $4.340B 90.37
Amedisys (AMED) United States $2.999B 21.24
Astrana Health (ASTH) United States $2.312B 31.26
LifeStance Health (LFST) United States $2.022B 0.00
Addus HomeCare (ADUS) United States $1.939B 27.74
U.S Physical Therapy (USPH) United States $1.388B 37.15
Pennant (PNTG) United States $0.677B 35.75
Aveanna Healthcare Holdings (AVAH) United States $0.492B 0.00
Atai Life Sciences (ATAI) Germany $0.224B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.016B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00